Hymovis™ Versus Placebo in Knee Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

February 28, 2013

Conditions
Knee Osteoarthritis
Interventions
DEVICE

Hymovis Intra-articular Injection

Hymovis Intra-articular injection

PROCEDURE

Phosphate Buffered Saline Injection

Placebo Intra-articular injection

Trial Locations (33)

Unknown

Achieve Clinical Research, LLC, Birmingham

Tucson Orthopaedic Institute, Tucson

Core Orthopaedic, Encinitas

San Diego Clinical Trials, San Diego

Norwalk Medical Group, Norwalk

Stamford Therapeutics Consortium, Stamford

Tampa Bay Medical Research, Clearwater

Homestead Clinical Research, Cutler Bay

SJS Clinical Research, DeFuniak Springs

Avail Clinical Research, DeLand

Riverside Clinical Research, Edgewater

The Andrews Institute, Gulf Breeze

Sun Coast Clinical Research, New Port Richey

Pensacola Research Consultants, Pensacola

Lakeview Medical Research, Summerfield

Drug Studies America, Marietta

Better Health Clinical Research, Newnan

Sonora Clinical Research, Boise

Rush University, Chicago

Benchmark Research, Metairie

UMass Memorial Medical Center, Worcester

Shores Rheumatology, Saint Clair Shores

Columbus Clinical Research, Columbus

Radiant Research, Columbus

Blair Orthopedics Associates & Sports Medicine, Altoona

Altoona Center for Clinical Research, Duncansville

University Orthopedic Center, State College

Radiant Research, Anderson

Radiant Research, Greer

Tekton Research, Austin

Martin Diagnostic Center, Tomball

Orthopaedic Specialty Clinic, Spokane

Latin Clinical Trial Center, San Juan

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY